Abstract
Objective
The Patient-Oriented Prostate Utility Scale (PORPUS) is a combined profile and utility-based quality of life measure for prostate cancer patients. Our objectives were to adapt the PORPUS into Spanish and to assess its acceptability, reliability, and validity.
Methods
The PORPUS was adapted into Spanish using forward and back translations and cognitive debriefing. PORPUS was administered jointly with the SF-36 and the Expanded Prostate Index Composite (EPIC) to 480 Spanish prostate cancer patients treated with radical prostatectomy or radiotherapy. The Spanish PORPUS scores’ distribution and reliability were examined and compared with the original instrument. To evaluate construct validity, relationships were assessed between PORPUS and other instruments (testing hypotheses of the original PORPUS study), and among known groups defined by side effect severity.
Results
Reliability coefficient was 0.76 (similar to the original PORPUS’ 0.81). Spanish PORPUS items presented correlations ranging 0.57–0.88 with the corresponding EPIC domains, as in the original PORPUS study (0.60–0.83). Both PORPUS-P and PORPUS-U showed significant differences and large effect sizes (0.94–1.90) when comparing severe versus no problem groups on urinary, bowel, sexual and hormonal side effects defined by EPIC.
Conclusions
A conceptually equivalent Spanish version was obtained, with high reliability and good construct validity, similar to the original Canadian PORPUS version. It can therefore be used to measure health-related quality of life and utilities in Spanish prostate cancer patients.
References
Rnic, K., Linden, W., Tudor, I., Pullmer, R., & Vodermaier, A. (2013). Measuring symptoms in localized prostate cancer: A systematic review of assessment instruments. Prostate Cancer and Prostatic Diseases, 16, 111–122.
Ritvo, P., Irvine, J., Naglie, G., Tomlinson, G., Bezjak, A., Matthew, A., et al. (2005). Reliability and validity of the PORPUS, a combined psychometric and utility-based quality-of-life instrument for prostate cancer. Journal of Clinical Epidemiology, 58, 466–474.
Tomlinson, G., Bremner, K. E., Ritvo, P., Naglie, G., & Krahn, M. D. (2012). Development and validation of a utility weighting function for the Patient-Oriented Prostate Utility Scale (PORPUS). Medical Decision Making, 32, 11–30.
Krahn, M., Ritvo, P., Irvine, J., Tomlinson, G., Bezjak, A., Trachtenberg, J., et al. (2000). Construction of the Patient-Oriented Prostate Utility Scale (PORPUS): A multiattribute health state classification system for prostate cancer. Journal of Clinical Epidemiology, 53, 920–930.
Ferrer, M., Suarez, J. F., Guedea, F., Fernandez, P., Macias, V., Marino, A., et al. (2008). Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer. International Journal of Radiation Oncology Biology Physics, 72, 421–432.
Alonso, J., Prieto, L., & Anto, J. M. (1995). The Spanish version of the SF-36 Health Survey (the SF-36 health questionnaire): An instrument for measuring clinical results. Medicina Clinica (Barc), 104, 771–776.
Batista-Miranda, J. E., Sevilla-Cecilia, C., Torrubia, R., Musquera, M., Huguet-Perez, J., Ponce, D. L. X., et al. (2003). Quality of life in prostate cancer patients and controls: Psychometric validation of the FACTP-4 in Spanish, and relation to urinary symptoms. Archivos Espanoles de Urologia, 56, 447–454.
Ferrer, M., Garin, O., Pera, J., Prats, J. M., Mendivil, J., Alonso, J., et al. (2009). Evaluation of the quality of life of patients with localized prostate cancer: Validation of the Spanish version of the EPIC. Medicina Clinica (Barc), 132, 128–135.
Pardo, Y., Guedea, F., Aguilo, F., Fernandez, P., Macias, V., Marino, A., et al. (2010). Quality-of-life impact of primary treatments for localized prostate cancer in patients without hormonal treatment. Journal of Clinical Oncology, 28, 4687–4696.
Torvinen, S., Farkkila, N., Sintonen, H., Saarto, T., Roine, R. P., & Taari, K. (2013). Health-related quality of life in prostate cancer. Acta Oncologica, 52, 1094–1101.
Scientific Advisory Committee of the Medical Outcomes Trust. (2002). Assessing health status and quality-of-life instruments: Attributes and review criteria. Quality of Life Research, 11, 193–205.
Krahn, M., Bremner, K. E., Tomlinson, G., Ritvo, P., Irvine, J., & Naglie, G. (2007). Responsiveness of disease-specific and generic utility instruments in prostate cancer patients. Quality of Life Research, 16, 509–522.
Badia, X., Roset, M., Herdman, M., & Kind, P. (2001). A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states. Medical Decision Making, 21, 7–16.
Burnand, B., Kernan, W. N., & Feinstein, A. R. (1990). Indexes and boundaries for “quantitative significance” in statistical decisions. Journal of Clinical Epidemiology, 43, 1273–1284.
Acknowledgments
Financial support for this study was provided by grant from DIUE de la Generalitat de Catalunya (2009 SGR 1095); and the Catalan Agency for Health Information, Assessment and Quality (grant AATRM 436/05/2008). The funding agreement ensures the authors’ independence in designing the study, interpreting the data, and writing and publishing the report.
Conflict of interest
None.
Author information
Authors and Affiliations
Consortia
Corresponding author
Rights and permissions
About this article
Cite this article
Ávila, M., Pardo, Y., Castells, M. et al. Adaptation and validation of the Spanish version of the Patient-Oriented Prostate Utility Scale (PORPUS). Qual Life Res 23, 2481–2487 (2014). https://doi.org/10.1007/s11136-014-0701-0
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11136-014-0701-0